The risk or severity of adverse effects can be increased when proparacaine is combined with Perospirone.


The risk or severity of adverse effects can be increased when losartan is combined with carprofen.


The risk or severity of adverse effects can be increased when lisinopril is combined with dipyridamole.


The risk or severity of adverse effects can be increased when midazolam is combined with MELPERONE.


The risk or severity of adverse effects can be increased when aspirin is combined with etodolac.


The risk or severity of adverse effects can be increased when ILOPROST is combined with TROLAMINE SALICYLATE.


The risk or severity of adverse effects can be increased when aspirin is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with maprotiline.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with mesoridazine.


The risk or severity of adverse effects can be increased when leflunomide is combined with DESONIDE.


The risk or severity of adverse effects can be increased when metoclopramide is combined with Asenapine.


The risk or severity of adverse effects can be increased when buspirone is combined with brotizolam.


The risk or severity of adverse effects can be increased when buspirone is combined with etizolam.


The risk or severity of adverse effects can be increased when bepridil is combined with thalidomide.


The risk or severity of adverse effects can be increased when temazepam is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when acemetacin is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when thalidomide is combined with acebutolol.


The risk or severity of adverse effects can be increased when sulfinpyrazone is combined with atorvastatin.


The risk or severity of adverse effects can be increased when carboprost trometamol is combined with ERGOTAMINE.


The risk or severity of adverse effects can be increased when etodolac is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when Vilazodone is combined with cabergoline.


The risk or severity of adverse effects can be increased when carvedilol is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when docetaxel is combined with Gefitinib.


The risk or severity of adverse effects can be increased when Pomalidomide is combined with clozapine.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when oxazepam is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with Mometasone.


The risk or severity of adverse effects can be increased when thiamylal is combined with ethosuximide.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Desloratadine.


The risk or severity of adverse effects can be increased when clorazepate is combined with felbamate.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with minoxidil.


The risk or severity of adverse effects can be increased when indapamide is combined with mecamylamine.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with metaraminol.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with dantrolene.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Pinaverium.


The risk or severity of adverse effects can be increased when amitriptyline is combined with clonazepam.


The risk or severity of adverse effects can be increased when ethosuximide is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when Propiverine is combined with oxymorphone.


The risk or severity of adverse effects can be increased when Naftifine is combined with PERHEXILINE.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with fludiazepam.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when Fesoterodine is combined with Normethadone.


The risk or severity of adverse effects can be increased when butorphanol is combined with clorazepate.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with pimozide.


The risk or severity of adverse effects can be increased when resveratrol is combined with triamcinolone.


The risk or severity of adverse effects can be increased when protriptyline is combined with Difenoxin.


The risk or severity of adverse effects can be increased when trimetrexate is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when loxapine is combined with clidinium.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with TROLEANDOMYCIN.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Tavaborole is combined with Pregabalin.


The risk or severity of adverse effects can be increased when naratriptan is combined with pimozide.


The risk or severity of adverse effects can be increased when fluoxetine is combined with Lurasidone.


The risk or severity of adverse effects can be increased when naratriptan is combined with sertraline.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when metoprolol is combined with captopril.


The risk or severity of adverse effects can be increased when valsartan is combined with losartan.


The risk or severity of adverse effects can be increased when celecoxib is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when fosinopril is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when oxazepam is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when losartan is combined with ramipril.


The risk or severity of adverse effects can be increased when losartan is combined with Masoprocol.


The risk or severity of adverse effects can be increased when methylphenidate is combined with clonidine.


The risk or severity of adverse effects can be increased when tolnaftate is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when loxapine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with QUINETHAZONE.


The risk or severity of adverse effects can be increased when pargyline is combined with Vilanterol.


The risk or severity of adverse effects can be increased when fenbufen is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when tizanidine is combined with hydralazine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when perphenazine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with fexofenadine.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with Bretylium.


The risk or severity of adverse effects can be increased when nilvadipine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when ketamine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when carbamazepine is combined with rasagiline.


The risk or severity of adverse effects can be increased when clonidine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when codeine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when codeine is combined with flunarizine.


The risk or severity of adverse effects can be increased when halothane is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Mometasone is combined with mefloquine.


The risk or severity of adverse effects can be increased when codeine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with METAXALONE.


The risk or severity of adverse effects can be increased when levorphanol is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when Agomelatine is combined with trimipramine.


The risk or severity of adverse effects can be increased when triazolam is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when Butethal is combined with maprotiline.


The risk or severity of adverse effects can be increased when Asenapine is combined with Lurasidone.


The risk or severity of adverse effects can be increased when prilocaine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when griseofulvin is combined with nitrendipine.


The risk or severity of adverse effects can be increased when moclobemide is combined with lithium ion.


The risk or severity of adverse effects can be increased when citalopram is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when HEROIN is combined with Iloperidone.


The risk or severity of adverse effects can be increased when papaverine is combined with Riociguat.


The risk or severity of adverse effects can be increased when loxapine is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when isoflurane is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when risperidone is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when sotalol is combined with captopril.


The risk or severity of adverse effects can be increased when pentazocine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Aliskiren.


The risk or severity of adverse effects can be increased when azelastine is combined with alclometasone.


The risk or severity of adverse effects can be increased when amphotericin b is combined with indapamide.


The risk or severity of adverse effects can be increased when azelastine is combined with mesalamine.


The risk or severity of adverse effects can be increased when BENZOYL PEROXIDE is combined with dapsone.


The risk or severity of adverse effects can be increased when rasagiline is combined with ritodrine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with fenoldopam.


The risk or severity of adverse effects can be increased when PREDNICARBATE is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when flurazepam is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when lidocaine is combined with scopolamine.


The risk or severity of adverse effects can be increased when pimozide is combined with brotizolam.


The risk or severity of adverse effects can be increased when Fluprednidene is combined with Demecarium.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Desloratadine.


The risk or severity of adverse effects can be increased when pergolide is combined with Quinine.


The risk or severity of adverse effects can be increased when zaleplon is combined with desipramine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with flunarizine.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with diflorasone.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when clomipramine is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with thiamylal.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with desipramine.


The risk or severity of adverse effects can be increased when promethazine is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when fluoxetine is combined with naratriptan.


The risk or severity of adverse effects can be increased when fluoxetine is combined with rizatriptan.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with halothane.


The risk or severity of adverse effects can be increased when risperidone is combined with thiothixene.


The risk or severity of adverse effects can be increased when methazolamide is combined with phenytoin.


The risk or severity of adverse effects can be increased when alclometasone is combined with ambenonium.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with Perospirone.


The risk or severity of adverse effects can be increased when oxycodone is combined with Retigabine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with methyldopa.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Telmisartan.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with apraclonidine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with mepivacaine.


The risk or severity of adverse effects can be increased when desipramine is combined with ritodrine.


The risk or severity of adverse effects can be increased when scopolamine is combined with Atracurium besylate.


The risk or severity of adverse effects can be increased when bumetanide is combined with nadolol.


The risk or severity of adverse effects can be increased when ethopropazine is combined with Normethadone.


The risk or severity of adverse effects can be increased when amisulpride is combined with Articaine.


The risk or severity of adverse effects can be increased when cetirizine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when prazosin is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when prazosin is combined with Metipranolol.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when ipratropium is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when moclobemide is combined with Remoxipride.


The risk or severity of adverse effects can be increased when moclobemide is combined with loxapine.


The risk or severity of adverse effects can be increased when floctafenine is combined with oxaprozin.


The risk or severity of adverse effects can be increased when amoxapine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when betaxolol is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when scopolamine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when CICLOPIROX is combined with nitrendipine.


The risk or severity of adverse effects can be increased when Eprosartan is combined with tolmetin.


The risk or severity of adverse effects can be increased when Nepafenac is combined with ibuprofen.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with promazine.


The risk or severity of adverse effects can be increased when isoflurane is combined with minoxidil.


The risk or severity of adverse effects can be increased when pirenzepine is combined with Normethadone.


The risk or severity of adverse effects can be increased when clozapine is combined with propranolol.


The risk or severity of adverse effects can be increased when Talniflumate is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when Butethal is combined with amoxapine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with selegiline.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with D-mannitol.


The risk or severity of adverse effects can be increased when Talniflumate is combined with Droxicam.


The risk or severity of adverse effects can be increased when Talniflumate is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when triprolidine is combined with Retigabine.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with Levomepromazine.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with clenbuterol.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with baclofen.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when mesoridazine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with carbamazepine.


The risk or severity of adverse effects can be increased when thioridazine is combined with tiagabine.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when thioridazine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when Voriconazole is combined with vinorelbine.


The risk or severity of adverse effects can be increased when dantrolene is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when doxepin is combined with Flibanserin.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with fludiazepam.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when estazolam is combined with bupivacaine.


The risk or severity of adverse effects can be increased when estazolam is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when tenoxicam is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when estazolam is combined with Etomidate.


The risk or severity of adverse effects can be increased when clonidine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when timolol is combined with papaverine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with mecamylamine.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with budesonide.


The risk or severity of adverse effects can be increased when pentamidine is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when promethazine is combined with olanzapine.


The risk or severity of adverse effects can be increased when pimozide is combined with Iloperidone.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Difenoxin.


The risk or severity of adverse effects can be increased when mirtazapine is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when nystatin is combined with nisoldipine.


The risk or severity of adverse effects can be increased when sulconazole is combined with diltiazem.


The risk or severity of adverse effects can be increased when propofol is combined with acebutolol.


The risk or severity of adverse effects can be increased when Eplerenone is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when Eplerenone is combined with felodipine.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with Droxicam.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with amoxapine.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with nortriptyline.


The risk or severity of adverse effects can be increased when venlafaxine is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with felodipine.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when Eprosartan is combined with Nepafenac.


The risk or severity of adverse effects can be increased when Calcifediol is combined with Calcipotriol.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when felbamate is combined with Retigabine.


The risk or severity of adverse effects can be increased when ethopropazine is combined with hydromorphone.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with Pipamperone.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when edrophonium is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when MORICIZINE is combined with paroxetine.


The risk or severity of adverse effects can be increased when loxapine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with fexofenadine.


The risk or severity of adverse effects can be increased when oxycodone is combined with propofol.


The risk or severity of adverse effects can be increased when oxycodone is combined with acetazolamide.


The risk or severity of adverse effects can be increased when isoflurane is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when propofol is combined with bromazepam.


The risk or severity of adverse effects can be increased when barnidipine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when D-mannitol is combined with Aliskiren.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with methyldopa.


The risk or severity of adverse effects can be increased when propofol is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Desloratadine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with apraclonidine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with zaleplon.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with mepivacaine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with paroxetine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with chlormezanone.


The risk or severity of adverse effects can be increased when ethopropazine is combined with oxycodone.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with doxepin.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with promethazine.


The risk or severity of adverse effects can be increased when morniflumate is combined with diflunisal.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Escitalopram.


The risk or severity of adverse effects can be increased when perphenazine is combined with trazodone.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Phenelzine.


The risk or severity of adverse effects can be increased when Torasemide is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when etodolac is combined with salicylamide.


The risk or severity of adverse effects can be increased when Retigabine is combined with nefazodone.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with enalapril.


The risk or severity of adverse effects can be increased when flurazepam is combined with Pipamperone.


The risk or severity of adverse effects can be increased when reserpine is combined with midazolam.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when lorazepam is combined with butamben.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when salicylic acid is combined with triamcinolone.


The risk or severity of adverse effects can be increased when thalidomide is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when gabapentin is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when buspirone is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with Normethadone.


The risk or severity of adverse effects can be increased when temazepam is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Conivaptan is combined with furosemide.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with timolol.


The risk or severity of adverse effects can be increased when Nepafenac is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when tretinoin is combined with Torasemide.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with duloxetine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with phenytoin.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with fluoxetine.


The risk or severity of adverse effects can be increased when prilocaine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Aclidinium is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when alprazolam is combined with halothane.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with desoximetasone.


The risk or severity of adverse effects can be increased when flurazepam is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when diazepam is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when clorazepate is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Olopatadine.


The risk or severity of adverse effects can be increased when alprazolam is combined with desipramine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Nebivolol.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Clevidipine.


The risk or severity of adverse effects can be increased when alprazolam is combined with lidocaine.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with tenoxicam.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Etomidate is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Conivaptan.


The risk or severity of adverse effects can be increased when RIMEXOLONE is combined with fleroxacin.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with nabumetone.


The risk or severity of adverse effects can be increased when ketamine is combined with Lurasidone.


The risk or severity of adverse effects can be increased when venlafaxine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with ketorolac.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with dantrolene.


The risk or severity of adverse effects can be increased when Torasemide is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when Olmesartan is combined with trandolapril.


The risk or severity of adverse effects can be increased when benzocaine is combined with topiramate.


The risk or severity of adverse effects can be increased when ipratropium is combined with procyclidine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Agomelatine.


The risk or severity of adverse effects can be increased when Torasemide is combined with lisinopril.


The risk or severity of adverse effects can be increased when mecamylamine is combined with quinapril.


The risk or severity of adverse effects can be increased when mecamylamine is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when MELPERONE is combined with clomipramine.


The risk or severity of adverse effects can be increased when clorazepate is combined with HEROIN.


The risk or severity of adverse effects can be increased when timolol is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with thiothixene.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with amitriptyline.


The risk or severity of adverse effects can be increased when Rufinamide is combined with reserpine.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Estrone sulfate is combined with galanthamine.


The risk or severity of adverse effects can be increased when alprazolam is combined with brotizolam.


The risk or severity of adverse effects can be increased when carprofen is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with Arformoterol.


The risk or severity of adverse effects can be increased when Rufinamide is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when sulpiride is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Rufinamide is combined with bromazepam.


The risk or severity of adverse effects can be increased when gabapentin is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when thiothixene is combined with Flibanserin.


The risk or severity of adverse effects can be increased when nitric oxide is combined with chloroquine.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with Deferasirox.


The risk or severity of adverse effects can be increased when benzocaine is combined with baclofen.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when diltiazem is combined with minoxidil.


The risk or severity of adverse effects can be increased when barnidipine is combined with MAGNESIUM HYDROXIDE.


The risk or severity of adverse effects can be increased when rescinnamine is combined with tenoxicam.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when meperidine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when rescinnamine is combined with ketorolac.


The risk or severity of adverse effects can be increased when Vildagliptin is combined with trandolapril.


The risk or severity of adverse effects can be increased when oxazepam is combined with Flupentixol.


The risk or severity of adverse effects can be increased when rescinnamine is combined with nabumetone.


The risk or severity of adverse effects can be increased when enflurane is combined with butamben.


The risk or severity of adverse effects can be increased when minoxidil is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when Isoconazole is combined with diltiazem.


The risk or severity of adverse effects can be increased when isoflurane is combined with Remoxipride.


The risk or severity of adverse effects can be increased when pentosan polysulfate is combined with Deferasirox.


The risk or severity of adverse effects can be increased when moclobemide is combined with Levalbuterol.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when isradipine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when chloroquine is combined with alclofenac.


The risk or severity of adverse effects can be increased when suprofen is combined with Icatibant.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with topiramate.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with fluocinonide.


The risk or severity of adverse effects can be increased when quinidine is combined with Butylscopolamine.


The risk or severity of adverse effects can be increased when nicergoline is combined with mifepristone.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with gabapentin.


The risk or severity of adverse effects can be increased when Agomelatine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when cabergoline is combined with arsenic trioxide.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with fludiazepam.


The risk or severity of adverse effects can be increased when clozapine is combined with methyldopa.


The risk or severity of adverse effects can be increased when clozapine is combined with Telmisartan.


The risk or severity of adverse effects can be increased when clozapine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when fenoprofen is combined with Clobetasone.


The risk or severity of adverse effects can be increased when cabergoline is combined with cilostazol.


The risk or severity of adverse effects can be increased when clozapine is combined with zaleplon.


The risk or severity of adverse effects can be increased when clozapine is combined with mepivacaine.


The risk or severity of adverse effects can be increased when meprobamate is combined with Agomelatine.


The risk or severity of adverse effects can be increased when niflumic acid is combined with salicylamide.


The risk or severity of adverse effects can be increased when oxazepam is combined with thiopental.


The risk or severity of adverse effects can be increased when cetirizine is combined with sertraline.


The risk or severity of adverse effects can be increased when salicylamide is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when lidocaine is combined with tetracaine.


The risk or severity of adverse effects can be increased when Tramadol is combined with triflupromazine.


The risk or severity of adverse effects can be increased when benzocaine is combined with oxprenolol.


The risk or severity of adverse effects can be increased when butamben is combined with citalopram.


The risk or severity of adverse effects can be increased when Sorafenib is combined with clozapine.


The risk or severity of adverse effects can be increased when nabumetone is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when benzocaine is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when benzocaine is combined with prazepam.


The risk or severity of adverse effects can be increased when Halazepam is combined with mesoridazine.


The risk or severity of adverse effects can be increased when ioversol is combined with metformin.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when Halazepam is combined with maprotiline.


The risk or severity of adverse effects can be increased when Tolcapone is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when procaine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when pentazocine is combined with lithium ion.


The risk or severity of adverse effects can be increased when pentazocine is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when nortriptyline is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when pentazocine is combined with Butethal.


The risk or severity of adverse effects can be increased when pentazocine is combined with amobarbital.


The risk or severity of adverse effects can be increased when butabarbital is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when cetirizine is combined with duloxetine.


The risk or severity of adverse effects can be increased when cetirizine is combined with fluoxetine.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when propofol is combined with Lurasidone.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with bumetanide.


The risk or severity of adverse effects can be increased when primidone is combined with levodopa.


The risk or severity of adverse effects can be increased when Eprosartan is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when minoxidil is combined with apraclonidine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with fexofenadine.


The risk or severity of adverse effects can be increased when nicergoline is combined with rabeprazole.


The risk or severity of adverse effects can be increased when isradipine is combined with losartan.


The risk or severity of adverse effects can be increased when morphine is combined with meperidine.


The risk or severity of adverse effects can be increased when temazepam is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when morphine is combined with prazosin.


The risk or severity of adverse effects can be increased when Escitalopram is combined with Perospirone.


The risk or severity of adverse effects can be increased when indomethacin is combined with Olopatadine.


The risk or severity of adverse effects can be increased when midazolam is combined with Pizotifen.


The risk or severity of adverse effects can be increased when olanzapine is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with Propacetamol.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with tiagabine.


The risk or severity of adverse effects can be increased when methysergide is combined with colchicine.


The risk or severity of adverse effects can be increased when Clofarabine is combined with timolol.


The risk or severity of adverse effects can be increased when linezolid is combined with periciazine.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with zonisamide.


The risk or severity of adverse effects can be increased when niflumic acid is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when butabarbital is combined with HEROIN.


The risk or severity of adverse effects can be increased when tolmetin is combined with amcinonide.


The risk or severity of adverse effects can be increased when halothane is combined with Lofexidine.


The risk or severity of adverse effects can be increased when BECLOMETHASONE DIPROPIONATE is combined with edrophonium.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with droxidopa.


The risk or severity of adverse effects can be increased when morphine is combined with Alvimopan.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when tolmetin is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when docetaxel is combined with goserelin.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Pizotifen.


The risk or severity of adverse effects can be increased when gabapentin is combined with quazepam.


The risk or severity of adverse effects can be increased when gabapentin is combined with prazepam.


The risk or severity of adverse effects can be increased when Fospropofol is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Perospirone is combined with Difenoxin.


The risk or severity of adverse effects can be increased when gabapentin is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when nimesulide is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when miconazole is combined with flunarizine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Paliperidone.


The risk or severity of adverse effects can be increased when tizanidine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when procarbazine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when meprobamate is combined with Etomidate.


The risk or severity of adverse effects can be increased when meprobamate is combined with bupivacaine.


The risk or severity of adverse effects can be increased when meprobamate is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when procarbazine is combined with metoclopramide.


The risk or severity of adverse effects can be increased when dibucaine is combined with Retigabine.


The risk or severity of adverse effects can be increased when indomethacin is combined with Mometasone.


The risk or severity of adverse effects can be increased when Telmisartan is combined with terazosin.


The risk or severity of adverse effects can be increased when meprobamate is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when Etidocaine is combined with trimipramine.


The risk or severity of adverse effects can be increased when perphenazine is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when quazepam is combined with felbamate.


The risk or severity of adverse effects can be increased when Ifenprodil is combined with aspirin.


The risk or severity of adverse effects can be increased when fenoldopam is combined with nitric oxide.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when topiramate is combined with dantrolene.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with nalbuphine.


The risk or severity of adverse effects can be increased when epirizole is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when epirizole is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when ropinirole is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when milrinone is combined with diflunisal.


The risk or severity of adverse effects can be increased when epoprostenol is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when suprofen is combined with Droxicam.


The risk or severity of adverse effects can be increased when suprofen is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with fosinopril.


The risk or severity of adverse effects can be increased when suprofen is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when tiagabine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with dopamine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when suprofen is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when Tolcapone is combined with clomipramine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Milnacipran.


The risk or severity of adverse effects can be increased when RIMEXOLONE is combined with physostigmine.


The risk or severity of adverse effects can be increased when zaleplon is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with tretinoin.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with ethotoin.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with fexofenadine.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with naratriptan.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with rizatriptan.


The risk or severity of adverse effects can be increased when carisoprodol is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Naftifine is combined with haloperidol.


The risk or severity of adverse effects can be increased when morphine is combined with doxepin.


The risk or severity of adverse effects can be increased when trichlormethiazide is combined with mecamylamine.


The risk or severity of adverse effects can be increased when enalapril is combined with nadolol.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Lurasidone.


The risk or severity of adverse effects can be increased when Nabilone is combined with Bretylium.


The risk or severity of adverse effects can be increased when bromazepam is combined with Desloratadine.


The risk or severity of adverse effects can be increased when amiodarone is combined with Enalaprilat.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with cinnarizine.


The risk or severity of adverse effects can be increased when ATROPINE is combined with Fesoterodine.


The risk or severity of adverse effects can be increased when promazine is combined with tetracaine.


The risk or severity of adverse effects can be increased when duloxetine is combined with sumatriptan.


The risk or severity of adverse effects can be increased when doxepin is combined with periciazine.


The risk or severity of adverse effects can be increased when clozapine is combined with gabapentin.


The risk or severity of adverse effects can be increased when rescinnamine is combined with Olsalazine.


The risk or severity of adverse effects can be increased when bepridil is combined with nadolol.


The risk or severity of adverse effects can be increased when bepridil is combined with bromocriptine.


The risk or severity of adverse effects can be increased when methscopolamine is combined with Tapentadol.


The risk or severity of adverse effects can be increased when estrone is combined with Ospemifene.


The risk or severity of adverse effects can be increased when buspirone is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when biperiden is combined with Methylscopolamine bromide.


The risk or severity of adverse effects can be increased when buspirone is combined with baclofen.


The risk or severity of adverse effects can be increased when Remoxipride is combined with primidone.


The risk or severity of adverse effects can be increased when Rufinamide is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when nortriptyline is combined with Almotriptan.


The risk or severity of adverse effects can be increased when Olmesartan is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when Conivaptan is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when Fospropofol is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Fospropofol is combined with amitriptyline.


The risk or severity of adverse effects can be increased when buprenorphine is combined with PAMABROM.


The risk or severity of adverse effects can be increased when salicylic acid is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when propofol is combined with Pipamperone.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Flupentixol.


The risk or severity of adverse effects can be increased when Olsalazine is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with rasagiline.


The risk or severity of adverse effects can be increased when Olsalazine is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when Tramadol is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Etomidate is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with TRIMETHAPHAN.


The risk or severity of adverse effects can be increased when salicylic acid is combined with dexamethasone.


The risk or severity of adverse effects can be increased when chlormezanone is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when pirenzepine is combined with olanzapine.


The risk or severity of adverse effects can be increased when Masoprocol is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when halothane is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when butorphanol is combined with clonidine.


The risk or severity of adverse effects can be increased when Tianeptine is combined with Sodium phosphate monobasic.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when doxorubicin is combined with clozapine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Tolvaptan.


The risk or severity of adverse effects can be increased when mesalamine is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with tolterodine.


The risk or severity of adverse effects can be increased when thiopental is combined with loratadine.


The risk or severity of adverse effects can be increased when tenoxicam is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when Eletriptan is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when butabarbital is combined with Articaine.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with Aliskiren.


The risk or severity of adverse effects can be increased when sulindac is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when Artemether is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when trandolapril is combined with acebutolol.


The risk or severity of adverse effects can be increased when nimodipine is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Remoxipride.


The risk or severity of adverse effects can be increased when fosinopril is combined with felodipine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when fosinopril is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when fosinopril is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with nimesulide.


The risk or severity of adverse effects can be increased when clonidine is combined with cilazapril.


The risk or severity of adverse effects can be increased when trandolapril is combined with captopril.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with Clobetasone.


The risk or severity of adverse effects can be increased when bromocriptine is combined with enalapril.


The risk or severity of adverse effects can be increased when labetalol is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when bromocriptine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when oxaprozin is combined with DESONIDE.


The risk or severity of adverse effects can be increased when indomethacin is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when protriptyline is combined with dobutamine.


The risk or severity of adverse effects can be increased when niflumic acid is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when mefloquine is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when perphenazine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when olanzapine is combined with loratadine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with nicotinamide.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with PHENYLACETIC ACID.


The risk or severity of adverse effects can be increased when floctafenine is combined with carprofen.


The risk or severity of adverse effects can be increased when nalbuphine is combined with PAMABROM.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with diphenhydramine.


The risk or severity of adverse effects can be increased when Telmisartan is combined with fenbufen.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with methyldopa.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with tiapride.


The risk or severity of adverse effects can be increased when hydroxyzine is combined with nefazodone.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with Deferasirox.


The risk or severity of adverse effects can be increased when risperidone is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when salicylic acid is combined with desoximetasone.


The risk or severity of adverse effects can be increased when prilocaine is combined with tetracaine.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with Telmisartan.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with alclofenac.


The risk or severity of adverse effects can be increased when Bretylium is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when zotepine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with Etidocaine.


The risk or severity of adverse effects can be increased when cilazapril is combined with salicylamide.


The risk or severity of adverse effects can be increased when hexetidine is combined with nisoldipine.


The risk or severity of adverse effects can be increased when diflunisal is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when clidinium is combined with duloxetine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when quetiapine is combined with tetracaine.


The risk or severity of adverse effects can be increased when clidinium is combined with fluoxetine.


The risk or severity of adverse effects can be increased when olanzapine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when dichlorphenamide is combined with acebutolol.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with midazolam.


The risk or severity of adverse effects can be increased when Desloratadine is combined with dantrolene.


The risk or severity of adverse effects can be increased when diclofenac is combined with salicylamide.


The risk or severity of adverse effects can be increased when flurazepam is combined with amoxapine.


The risk or severity of adverse effects can be increased when butalbital is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when tacrolimus is combined with Gallium nitrate.


The risk or severity of adverse effects can be increased when flurazepam is combined with nortriptyline.


The risk or severity of adverse effects can be increased when suprofen is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when methysergide is combined with lomustine.


The risk or severity of adverse effects can be increased when flurandrenolide is combined with donepezil.


The risk or severity of adverse effects can be increased when methysergide is combined with mitoxantrone.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when methysergide is combined with bromocriptine.


The risk or severity of adverse effects can be increased when Paliperidone is combined with cetirizine.


The risk or severity of adverse effects can be increased when pentazocine is combined with etizolam.


The risk or severity of adverse effects can be increased when primidone is combined with Desloratadine.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with scopolamine.


The risk or severity of adverse effects can be increased when Masoprocol is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when Miltefosine is combined with manidipine.


The risk or severity of adverse effects can be increased when Butethal is combined with tiapride.


The risk or severity of adverse effects can be increased when bromazepam is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when triazolam is combined with Etidocaine.


The risk or severity of adverse effects can be increased when Miltefosine is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when Spirapril is combined with azelastine.


The risk or severity of adverse effects can be increased when Pirlindole is combined with ARBUTAMINE.


The risk or severity of adverse effects can be increased when Miltefosine is combined with Efonidipine.


The risk or severity of adverse effects can be increased when Miltefosine is combined with Lacidipine.


The risk or severity of adverse effects can be increased when morphine is combined with captopril.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with ramipril.


The risk or severity of adverse effects can be increased when morphine is combined with oxymorphone.


The risk or severity of adverse effects can be increased when morphine is combined with acebutolol.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with valsartan.


The risk or severity of adverse effects can be increased when morphine is combined with zopiclone.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with Droxicam.


The risk or severity of adverse effects can be increased when imipramine is combined with phentolamine.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with Propacetamol.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when pimozide is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Sitaxsentan.


The risk or severity of adverse effects can be increased when morphine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when dexamethasone is combined with donepezil.


The risk or severity of adverse effects can be increased when Nepafenac is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when methylergonovine is combined with astemizole.


The risk or severity of adverse effects can be increased when methylergonovine is combined with prednisone.


The risk or severity of adverse effects can be increased when ethotoin is combined with clomipramine.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when morphine is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when D-mannitol is combined with terazosin.


The risk or severity of adverse effects can be increased when tetracaine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when tetracaine is combined with Normethadone.


The risk or severity of adverse effects can be increased when Clofarabine is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when risperidone is combined with levorphanol.


The risk or severity of adverse effects can be increased when risperidone is combined with perphenazine.


The risk or severity of adverse effects can be increased when tiapride is combined with phenytoin.


The risk or severity of adverse effects can be increased when Naftifine is combined with alclofenac.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with meclizine.


The risk or severity of adverse effects can be increased when Eletriptan is combined with metoclopramide.


The risk or severity of adverse effects can be increased when HEROIN is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with metaproterenol.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with clozapine.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with haloperidol.


The risk or severity of adverse effects can be increased when methylergonovine is combined with rivastigmine.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with propofol.


The risk or severity of adverse effects can be increased when efavirenz is combined with levodopa.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Halobetasol.


The risk or severity of adverse effects can be increased when Masoprocol is combined with paramethasone.


The risk or severity of adverse effects can be increased when dichlorphenamide is combined with primidone.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when thiothixene is combined with etizolam.


The risk or severity of adverse effects can be increased when risperidone is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Paliperidone.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with salicylic acid.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with quetiapine.


The risk or severity of adverse effects can be increased when cabergoline is combined with mefloquine.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with dipyridamole.


The risk or severity of adverse effects can be increased when phenylephrine is combined with PSEUDOEPHEDRINE.


The risk or severity of adverse effects can be increased when protriptyline is combined with buspirone.


The risk or severity of adverse effects can be increased when BECLOMETHASONE DIPROPIONATE is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when norepinephrine is combined with metaproterenol.


The risk or severity of adverse effects can be increased when thiamylal is combined with efavirenz.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Canrenoic acid.


The risk or severity of adverse effects can be increased when Butethal is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when oxymorphone is combined with brotizolam.


The risk or severity of adverse effects can be increased when cyclosporin A is combined with bepridil.


The risk or severity of adverse effects can be increased when prazepam is combined with Fospropofol.


The risk or severity of adverse effects can be increased when Butethal is combined with glutethimide.


The risk or severity of adverse effects can be increased when raloxifene is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Vilazodone is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when prednisone is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when methylergonovine is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when trazodone is combined with cetirizine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with benzocaine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with vigabatrin.


The risk or severity of adverse effects can be increased when trazodone is combined with protriptyline.


The risk or severity of adverse effects can be increased when imipramine is combined with nitric oxide.


The risk or severity of adverse effects can be increased when imipramine is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when alclometasone is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when Ciclesonide is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with tizanidine.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with amitriptyline.


The risk or severity of adverse effects can be increased when cocaine is combined with felbamate.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with Tolcapone.


The risk or severity of adverse effects can be increased when labetalol is combined with terbutaline.


The risk or severity of adverse effects can be increased when dyclonine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with oxymorphone.


The risk or severity of adverse effects can be increased when labetalol is combined with Eprosartan.


The risk or severity of adverse effects can be increased when nabumetone is combined with Tixocortol.


The risk or severity of adverse effects can be increased when pramipexole is combined with valsartan.


The risk or severity of adverse effects can be increased when procaine is combined with loratadine.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with Halobetasol.


The risk or severity of adverse effects can be increased when Lacidipine is combined with MAGNESIUM HYDROXIDE.


The risk or severity of adverse effects can be increased when nortriptyline is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when meperidine is combined with Etidocaine.


The risk or severity of adverse effects can be increased when cilnidipine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with efavirenz.


The risk or severity of adverse effects can be increased when Normethadone is combined with Drospirenone.


The risk or severity of adverse effects can be increased when METHSUXIMIDE is combined with Milnacipran.


The risk or severity of adverse effects can be increased when oxycodone is combined with triamterene.


The risk or severity of adverse effects can be increased when propofol is combined with timolol.


The risk or severity of adverse effects can be increased when Dothiepin is combined with Salbutamol.


The risk or severity of adverse effects can be increased when amoxapine is combined with doxepin.


The risk or severity of adverse effects can be increased when Pentolinium is combined with nalbuphine.


The risk or severity of adverse effects can be increased when dyclonine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with flunisolide.


The risk or severity of adverse effects can be increased when methscopolamine is combined with codeine.


The risk or severity of adverse effects can be increased when amoxapine is combined with nefazodone.


The risk or severity of adverse effects can be increased when propofol is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when Nabilone is combined with fosinopril.


The risk or severity of adverse effects can be increased when trazodone is combined with Normethadone.


The risk or severity of adverse effects can be increased when fenoprofen is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when propofol is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when Lurasidone is combined with mepivacaine.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Lacidipine is combined with lovastatin.


The risk or severity of adverse effects can be increased when apomorphine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with Droxicam.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Agomelatine.


The risk or severity of adverse effects can be increased when risperidone is combined with Melatonin.


The risk or severity of adverse effects can be increased when Carfilzomib is combined with clozapine.


The risk or severity of adverse effects can be increased when clonidine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when risperidone is combined with clonazepam.


The risk or severity of adverse effects can be increased when risperidone is combined with promethazine.


The risk or severity of adverse effects can be increased when Olmesartan is combined with quetiapine.


The risk or severity of adverse effects can be increased when prilocaine is combined with Fospropofol.


The risk or severity of adverse effects can be increased when Normethadone is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when isoflurane is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when proparacaine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when leflunomide is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when butorphanol is combined with Desloratadine.


The risk or severity of adverse effects can be increased when etizolam is combined with dantrolene.


The risk or severity of adverse effects can be increased when butorphanol is combined with zaleplon.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when Mometasone is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with propoxyphene.


The risk or severity of adverse effects can be increased when dyclonine is combined with clidinium.


The risk or severity of adverse effects can be increased when Talniflumate is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when Valganciclovir is combined with zalcitabine.


The risk or severity of adverse effects can be increased when Etomidate is combined with maprotiline.


The risk or severity of adverse effects can be increased when fenoprofen is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when Etomidate is combined with mesoridazine.


The risk or severity of adverse effects can be increased when fludiazepam is combined with sertraline.


The risk or severity of adverse effects can be increased when fenoprofen is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with butalbital.


The risk or severity of adverse effects can be increased when trimipramine is combined with clenbuterol.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with valsartan.


The risk or severity of adverse effects can be increased when propofol is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Butethal is combined with fluoxetine.


The risk or severity of adverse effects can be increased when Artemether is combined with bepridil.


The risk or severity of adverse effects can be increased when quetiapine is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when Butethal is combined with duloxetine.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with nortriptyline.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with amoxapine.


The risk or severity of adverse effects can be increased when Tavaborole is combined with Amrinone.


The risk or severity of adverse effects can be increased when thiamylal is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when Eletriptan is combined with moclobemide.


The risk or severity of adverse effects can be increased when acemetacin is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with Deferasirox.


The risk or severity of adverse effects can be increased when Caspofungin is combined with nimesulide.


The risk or severity of adverse effects can be increased when Alogliptin is combined with fosinopril.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with prazepam.


The risk or severity of adverse effects can be increased when nimodipine is combined with dipyridamole.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when cabergoline is combined with dimethyl sulfoxide.


The risk or severity of adverse effects can be increased when ondansetron is combined with METAXALONE.


The risk or severity of adverse effects can be increased when diclofenac is combined with prednisone.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when alclofenac is combined with Mometasone.


The risk or severity of adverse effects can be increased when diclofenac is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when secobarbital is combined with sulpiride.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Apixaban is combined with Nintedanib.


The risk or severity of adverse effects can be increased when sertraline is combined with sulpiride.


The risk or severity of adverse effects can be increased when isoflurane is combined with propranolol.


The risk or severity of adverse effects can be increased when Nabilone is combined with Nebivolol.


The risk or severity of adverse effects can be increased when glutethimide is combined with paroxetine.


The risk or severity of adverse effects can be increased when diclofenac is combined with nimesulide.


The risk or severity of adverse effects can be increased when isoflurane is combined with clonidine.


The risk or severity of adverse effects can be increased when fosinopril is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with ethotoin.


The risk or severity of adverse effects can be increased when brotizolam is combined with doxepin.


The risk or severity of adverse effects can be increased when nilvadipine is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when Olmesartan is combined with propranolol.


The risk or severity of adverse effects can be increased when Olmesartan is combined with fenoprofen.


The risk or severity of adverse effects can be increased when brotizolam is combined with nefazodone.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with equilin.


The risk or severity of adverse effects can be increased when oxybutynin is combined with meperidine.


The risk or severity of adverse effects can be increased when apraclonidine is combined with cilazapril.


The risk or severity of adverse effects can be increased when carbamazepine is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when haloperidol is combined with dibucaine.


The risk or severity of adverse effects can be increased when fosinopril is combined with ketoprofen.


The risk or severity of adverse effects can be increased when celecoxib is combined with epirizole.


The risk or severity of adverse effects can be increased when ondansetron is combined with ethosuximide.


The risk or severity of adverse effects can be increased when indomethacin is combined with salicylamide.


The risk or severity of adverse effects can be increased when Difenoxin is combined with sertraline.


The risk or severity of adverse effects can be increased when Normethadone is combined with spironolactone.


The risk or severity of adverse effects can be increased when Normethadone is combined with methocarbamol.


The risk or severity of adverse effects can be increased when Normethadone is combined with triprolidine.


The risk or severity of adverse effects can be increased when betaxolol is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when midazolam is combined with benzocaine.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when isoflurane is combined with clomipramine.


The risk or severity of adverse effects can be increased when Naftifine is combined with niflumic acid.


The risk or severity of adverse effects can be increased when meperidine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when oxaprozin is combined with epirizole.


The risk or severity of adverse effects can be increased when dantrolene is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with butamben.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when meclizine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when protriptyline is combined with maprotiline.


The risk or severity of adverse effects can be increased when azelastine is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when dantrolene is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when glutethimide is combined with Agomelatine.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when valsartan is combined with minoxidil.


The risk or severity of adverse effects can be increased when pentazocine is combined with zopiclone.


The risk or severity of adverse effects can be increased when secobarbital is combined with maprotiline.


The risk or severity of adverse effects can be increased when quinapril is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when streptozocin is combined with clozapine.


The risk or severity of adverse effects can be increased when Paliperidone is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Paliperidone is combined with zotepine.


The risk or severity of adverse effects can be increased when pentazocine is combined with oxymorphone.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Idelalisib.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with brotizolam.


The risk or severity of adverse effects can be increased when sulindac is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when bupivacaine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when celecoxib is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when bromazepam is combined with etizolam.


The risk or severity of adverse effects can be increased when nefazodone is combined with tiapride.


The risk or severity of adverse effects can be increased when trandolapril is combined with tolmetin.


The risk or severity of adverse effects can be increased when codeine is combined with trichlormethiazide.


The risk or severity of adverse effects can be increased when etizolam is combined with flunarizine.


The risk or severity of adverse effects can be increased when CICLOPIROX is combined with eperisone.


The risk or severity of adverse effects can be increased when codeine is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when isoflurane is combined with thiothixene.


The risk or severity of adverse effects can be increased when isoflurane is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when phenobarbital is combined with Remoxipride.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Lapatinib.


The risk or severity of adverse effects can be increased when meclizine is combined with primidone.


The risk or severity of adverse effects can be increased when mepivacaine is combined with clonidine.


The risk or severity of adverse effects can be increased when zotepine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when phentolamine is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when Desloratadine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when phenobarbital is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when Desloratadine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when nisoldipine is combined with lisinopril.


The risk or severity of adverse effects can be increased when selegiline is combined with TAMSULOSIN.


The risk or severity of adverse effects can be increased when selegiline is combined with Eplerenone.


The risk or severity of adverse effects can be increased when selegiline is combined with methazolamide.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when Torasemide is combined with apraclonidine.


The risk or severity of adverse effects can be increased when Torasemide is combined with Telmisartan.


The risk or severity of adverse effects can be increased when selegiline is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when prazepam is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when tretinoin is combined with Bretylium.


The risk or severity of adverse effects can be increased when butabarbital is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when rescinnamine is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when epirizole is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when epirizole is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when LEVOBUNOLOL is combined with floctafenine.


The risk or severity of adverse effects can be increased when oxazepam is combined with triflupromazine.


The risk or severity of adverse effects can be increased when tizanidine is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with Normethadone.


The risk or severity of adverse effects can be increased when tizanidine is combined with felodipine.


The risk or severity of adverse effects can be increased when triazolam is combined with HEROIN.


The risk or severity of adverse effects can be increased when Clofarabine is combined with prazosin.


The risk or severity of adverse effects can be increased when tizanidine is combined with irbesartan.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with diflorasone.


The risk or severity of adverse effects can be increased when perphenazine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with atenolol.


The risk or severity of adverse effects can be increased when Melatonin is combined with tetracaine.


The risk or severity of adverse effects can be increased when propofol is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when proparacaine is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when tropicamide is combined with Butylscopolamine.


The risk or severity of adverse effects can be increased when propofol is combined with amisulpride.


The risk or severity of adverse effects can be increased when Metixene is combined with oxymorphone.


The risk or severity of adverse effects can be increased when temazepam is combined with METHOHEXITAL.


The risk or severity of adverse effects can be increased when temazepam is combined with chlordiazepoxide.


The risk or severity of adverse effects can be increased when temazepam is combined with duloxetine.


The risk or severity of adverse effects can be increased when Linagliptin is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Levalbuterol.


The risk or severity of adverse effects can be increased when topiramate is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when rizatriptan is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when citalopram is combined with procarbazine.


The risk or severity of adverse effects can be increased when Lasofoxifene is combined with Ospemifene.


The risk or severity of adverse effects can be increased when zopiclone is combined with cetirizine.


The risk or severity of adverse effects can be increased when sumatriptan is combined with maprotiline.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with triamcinolone.


The risk or severity of adverse effects can be increased when Toloxatone is combined with linezolid.


The risk or severity of adverse effects can be increased when zopiclone is combined with protriptyline.


The risk or severity of adverse effects can be increased when thioridazine is combined with amobarbital.


The risk or severity of adverse effects can be increased when ritodrine is combined with isoproterenol.


The risk or severity of adverse effects can be increased when Rufinamide is combined with propofol.


The risk or severity of adverse effects can be increased when nicergoline is combined with gemfibrozil.


The risk or severity of adverse effects can be increased when FLUOCORTOLONE is combined with fleroxacin.


The risk or severity of adverse effects can be increased when Halazepam is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when meclizine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when floctafenine is combined with antipyrine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with pimozide.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with sotalol.


The risk or severity of adverse effects can be increased when brotizolam is combined with Normethadone.


The risk or severity of adverse effects can be increased when codeine is combined with meprobamate.


The risk or severity of adverse effects can be increased when propofol is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with METAXALONE.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when METAXALONE is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when trazodone is combined with Cariprazine.


The risk or severity of adverse effects can be increased when Nepafenac is combined with Tixocortol.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with ILOPROST.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with benzocaine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with zotepine.


The risk or severity of adverse effects can be increased when meprobamate is combined with zotepine.


The risk or severity of adverse effects can be increased when Sodium oxybate is combined with venlafaxine.


The risk or severity of adverse effects can be increased when amoxapine is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when captopril is combined with hydralazine.


The risk or severity of adverse effects can be increased when Torasemide is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with pimozide.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Normethadone.


The risk or severity of adverse effects can be increased when tenoxicam is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when clorazepate is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when temazepam is combined with morphine.


The risk or severity of adverse effects can be increased when morniflumate is combined with ADAPALENE.


The risk or severity of adverse effects can be increased when temazepam is combined with bupivacaine.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with nortriptyline.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with ADAPALENE.